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OBJECTIVE The purpose of this study was to determine the efficacy of atrial pacing in the prevention of
atrial fibrillation following cardiovascular surgery.
BACKGROUND Although pharmacologic therapy has been used to help prevent postoperative atrial fibrilla-
tion, it suffers from limited efficacy and adverse effects. In the nonoperative setting, novel
pacing strategies have been shown to reduce recurrences of atrial fibrillation and prolong
arrhythmia-free periods in patients with paroxysmal atrial arrhythmias.
METHODS A total of 154 patients (115 men; mean age, 65 6 10 years; ejection fraction, 53 6 10%)
undergoing cardiac surgery (coronary artery bypass surgery, 88.3%; aortic valve replacement,
4.5%; coronary bypass 1 aortic valve replacement, 7.1%) had right and left atrial epicardial
pacing electrodes placed at the time of surgery. Patients were randomized to either no pacing,
right atrial (RAP), left atrial (LAP) or biatrial pacing (BAP) for 72 h after surgery.
Beta-adrenergic blocking agents were administered concurrently to all patients following
surgery.
RESULTS There was a reduction in the incidence of postoperative atrial fibrillation from 37.5% in
patients receiving no postoperative pacing to 17% (p , 0.005) in patients assigned to one of
the three pacing strategies. The length of hospital stay was reduced by 22% from 7.8 6 3.7
days to 6.1 6 2.3 days (p 5 0.003) in patients assigned to postoperative atrial pacing. The
incidence of atrial fibrillation was lower in each of the paced groups (RAP, 8%; LAP, 20%;
BAP, 26%) compared with patients who did not receive postoperative pacing (37.5%).
CONCLUSION Postoperative atrial pacing, in conjunction with beta-blockade, significantly reduced both the
incidence of atrial fibrillation and the length of hospital stay following cardiovascular surgery.
Additional studies are needed to determine the most effective anatomic pacing site. (J Am
Coll Cardiol 2000;35:1416–22) © 2000 by the American College of Cardiology
Atrial fibrillation (AF) is a common complication in the
setting of cardiovascular surgery. Of the estimated 300,000
patients undergoing coronary artery bypass grafting
(CABG) surgery annually, between 20% and 40% will have
development of AF in the week following surgery (1,2). The
occurrence of postoperative AF has significant implications
both in terms of morbidity and with respect to utilization of
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hospital resources. In addition, there is a higher incidence of
postoperative congestive heart failure, renal insufficiency,
infection and neurologic injury in patients with postopera-
tive AF (3). The prolonged length of hospital stay and
increased hospital charges that accompany postoperative AF
are a major contributing factor to the health-care costs
associated with coronary artery bypass surgery.
Beta-adrenergic blocking agents have consistently been
shown to reduce the incidence of postoperative AF (1,4–9).
Two meta-analyses found beta-blockers to be highly effec-
tive in preventing the occurrence of postoperative AF (1,9).
In fact, beta-blockers have had a beneficial effect on post-
operative AF in nearly every study performed. More re-
cently, several studies have demonstrated the potential
efficacy of amiodarone and sotalol as prophylactic agents for
the prevention of postoperative AF (10–12).
A growing body of data, in the nonoperative setting, have
suggested that innovative pacing therapies such as dual site
atrial pacing may decrease the incidence of paroxysmal AF
(13,14). As a result, we looked at the feasibility of atrial
pacing following coronary artery bypass surgery. Preliminary
reports indicate that atrial-based pacing may be performed
safely in the postoperative setting, but data regarding the
effectiveness of postoperative pacing in reducing the inci-
dence of postoperative AF are scant. In a recent study by
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Gerstenfeld and colleagues (15), no significant reduction in
postoperative AF was found with either right atrial (RAP)
or biatrial pacing (BAP); however, a trend toward a reduc-
tion in AF was observed in patients who received beta-
blockers in conjunction with postoperative pacing (15).
The present study was designed to assess the efficacy of
prophylactic atrial-based pacing, in conjunction with beta-
blockers, in the prevention of postoperative AF. In addition,
we sought to determine if there was a selective benefit to
RAP, left (LAP), or BAP in the prevention of AF following
cardiac surgery.
METHODS
Patient selection. Patients 18 years of age and older who
were scheduled to undergo either CABG or aortic valve
surgery were screened for participation in the study. In-
formed consent was obtained from all patients in accordance
with a protocol that had been approved by the Institutional
Review Board at Georgetown University prior to surgery.
Patients were randomly assigned to one of four strategies:
no postoperative pacing (NAP), RAP, LAP, or BAP.
Patients were excluded from the study if there was a
documented history of AF in the 24 h preceding surgery, if
they were receiving an antiarrhythmic agent or if they were
not in sinus rhythm at the time of surgery.
Surgical procedure and postoperative pacing protocol.
Patients underwent cardiovascular surgery utilizing standard
surgical techniques. After completion of the surgical proce-
dure, but before discontinuation of cardiopulmonary bypass,
the lateral wall of the right atrium and the right lateral
aspect of the left atrium were exposed. Two epicardial
pacing electrodes were placed into the left atrial myocar-
dium just inferior to the origin of the right superior
pulmonary vein. The RAP electrodes were then placed in a
similar manner on the posterior aspect of the right atrium
where the atrial wall is thicker. Finally, a set of electrodes
was attached to the right anterior ventricular wall. The
pacing electrodes were held in place with absorbable clips.
The atrial electrodes were brought out from the mediasti-
num to the right of the median sternotomy incision. The
electrodes were secured to the skin at their exit sites using
skin sutures.
On return from the operating room, all patients had their
epicardial pacing electrodes connected to an external tem-
porary dual-chamber pulse generator (Medtronic model
5345; Minneapolis, Minnesota). The pair of RAP elec-
trodes were connected to the atrial ports of the pulse
generator, while the pair of LAP electrodes were connected
to the ventricular ports. When RAP was desired, the
pacemaker was programmed in the AAI mode, whereas it
was programmed in the VVI mode for LAP. For BAP, the
pacemaker was programmed in the DDD mode with the
atrioventricular delay set to its lowest value (i.e., 6 ms). The
pacing rate was then programmed based on the native heart
rate (Table 1). Patients in the NAP group were not paced
unless clinically indicated (pulse ,50 beats/min or systolic
blood pressure ,100 mm Hg). RAP and LAP thresholds as
well as sensitivity were determined every 8 h, and outputs
were programmed accordingly to give a twofold safety
margin.
In accordance with the randomization protocol, pacing
was started as soon as possible on returning from the
operating room and was continued for 72 h. The paced rate
was adjusted whenever the native heart rate equaled or
exceeded the paced rate (Table 1). Patients underwent
continuous electrocardiographic monitoring for at least 96 h
following surgery utilizing a centralized cardiac telemetry
system (Marquette; Milwaukee, Wisconsin) equipped with
arrhythmia and rate detection alarm triggers. After 96 h,
patients were monitored through a combination of teleme-
try and daily electrocardiograms. Two “blinded” cardiolo-
gists reviewed all recorded electrocardiographic data daily.
Beta-blockers were administered postoperatively to all pa-
tients unless contraindicated by bradycardia (heart rate ,60
beats/min), heart block, hypotension (systolic blood pres-
sure ,90 mm Hg) or significant bronchospasm. Patients
received a 5-mg test dose of propranolol orally immediately
following extubation and the dose was titrated to a target
dose of 80 mg daily (20 mg orally four times daily).
Outcome measures. The primary end point of the study
was the occurrence of AF lasting .1 h or resulting in
hemodynamic compromise necessitating electrical or chem-
ical cardioversion. The secondary end point was the length
of hospital stay that was defined as the length of time from
surgery until hospital discharge.
Statistics. A sample size of 150 patients was required to
detect a reduction in postoperative AF from 40% in non-
paced patients to 15% in patients receiving a pacing strategy
(using a significance level of 5% and a power of 80%). All
data were initially analyzed on an intention-to-treat basis.
An on-treatment analysis was then performed on patients
Abbreviations and Acronyms
AF 5 atrial fibrillation
BAP 5 biatrial pacing
CABG 5 coronary artery bypass grafting
LAP 5 left atrial pacing
NAP 5 no pacing
RAP 5 right atrial pacing
Table 1. Pacing Protocol
Native Heart Rate
(Beats/min)
Pacing Rate
(Pulses/min)
,80 100
80–89 105
90–100 110
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who had received continuous pacing for 72 h. Statistical
analyses were by two-tailed Student’s t test for continuous
data and chi-square for categorical data. Comparisons
between groups were performed with analysis of variance
with adjustment for multiple comparisons. Statistics were
calculated using software (SPSS version 8.0; SPSS Inc;
Chicago, Illinois). Statistical significance was considered
present at a p value of ,0.05.
RESULTS
Patient characteristics. A total of 154 patients met the
inclusion criteria and were included in the study. There were
115 men (73%) with a mean age of 65 6 10 years. The
mean ejection fraction determined preoperatively by cardiac
catheterization was 53 6 10%. One hundred thirty-six
patients underwent CABG surgery alone, 7 patients had
isolated aortic valve replacement and the remaining 11
patients underwent combined CABG and aortic valve
surgery. For the group as a whole, intraoperative aortic cross
clamp time was 75 6 25 min while bypass time was 115 6
31 min. There were no significant differences in either the
baseline characteristics (Table 2) or operative data (Table 3)
for patients in the NAP, RAP, LAP and BAP groups.
Postoperative beta-blockers and feasibility of pacing.
Postoperative beta-blocker therapy was started in all pa-
tients without contraindications. There was no significant
difference between the groups with respect to the percentage
of patients receiving beta-blockers, the time until receipt of
the first dose of beta-blocker following surgery or the mean
dose of beta-blockers received during the postoperative
period (Table 4).
There were significant differences in the ability to main-
tain continuous pacing among the different groups. Right
atrial pacing was maintained for the entire 72-h period
without difficulty in most patients (90%); however, both
LAP and BAP were more problematic. Inability to maintain
Table 2. Baseline Patient Characteristics
NAP
(n 5 48)
RAP
(n 5 40)
LAP
(n 5 35)
BAP
(n 5 31)
p
Value
Age (yr) 66 6 10.9 64.1 6 9.1 66.3 6 9.5 64.9 6 9.9 NS
Preoperative ejection
fraction (%)
52.4 6 11.8 53.3 6 9.1 53.3 6 8.4 52.3 6 9.5 NS
Medical history (%)
Hypertension 57 68 65 42 NS
Myocardial infarction 30 28 46 31 NS
Congestive heart failure 18 17 8 8 NS
Thyroid disease 17 8 4 8 NS
Atrial fibrillation 3 4 0 0 NS
COPD 7 16 19 23 NS
Diabetes 27 40 35 24 NS
Cerebrovascular accident 13 4 15 8 NS
Preoperative medications
Beta-adrenergic blockers 53 67 65 54 NS
Digitalis 6 11 11 16 NS
Aspirin 58 73 73 68 NS
Calcium channel blockers 25 30 8 19 NS
BAP 5 biatrial pacing; COPD 5 chronic obstructive pulmonary disease; LAP 5 left atrial pacing; NAP 5 no atrial pacing; RAP 5 right atrial pacing.
Table 3. Baseline Operative Data
NAP RAP LAP BAP
p
Value
Surgical procedure (%)
Coronary artery bypass 86 96 80 94 NS
Aortic valve surgery 8 2 6 0 NS
Coronary artery bypass and AVR 6 2 14 6 NS
No. of vessels grafted 2.7 6 1.2 3.1 6 0.9 3.0 6 0.9 3.2 6 0.85 NS
Aortic cross-clamp time (min) 72 6 43 70 6 17 85 6 32 74 6 28 NS
Bypass-pump time (min) 112 6 27 108 6 27 124 6 36 117 6 35 NS
Magnesium* 2.1 6 0.3 2.1 6 0.5 2.0 6 0.3 2.0 6 0.2 NS
Potassium* 4.5 6 0.4 4.5 6 0.5 4.4 6 0.3 4.6 6 0.6 NS
*Values for magnesium and potassium were obtained on the morning of the first postoperative day.
AVR 5 aortic valve replacement; BAP 5 biatrial pacing; LAP 5 left atrial pacing; NAP 5 no atrial pacing; RAP 5 right atrial pacing.
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pacing either as a result of diaphragmatic stimulation or
high thresholds occurred in 23% of patients assigned to
LAP and 33% of those assigned to BAP. In addition, 19%
of patients randomized to the NAP group required some
form of postoperative pacing due to bradycardia, heart block
or hypotension. There were no complications associated
with the placement, maintenance or removal of the atrial
pacing electrodes.
Efficacy of postoperative pacing. As a group, patients who
were assigned to one of the three pacing strategies had a
significantly lower incidence of postoperative AF compared
with patients who were randomized to an NAP strategy
(17% vs. 37.5%; p , 0.005). The mean time from surgery
until the onset of postoperative AF was 54 6 44 h and it did
not differ significantly between groups.
The proportion of patients developing postoperative AF
was lower in each of the paced groups when compared with
patients assigned to NAP (Fig. 1). Atrial fibrillation oc-
curred in 8% of patients assigned to RAP, 20% with LAP
and 26% with BAP. This was in contrast to the 37.5%
incidence of postoperative AF present in patients assigned
to the NAP strategy.
Comparisons among each of the three pacing strategies
demonstrated that patients assigned to RAP had a 79%
reduction in the incidence of postoperative AF (RAP, 8%;
NAP, 37.5%; p 5 0.002). Although the incidence of
postoperative AF was lower in both the LAP group (NAP
vs. LAP; p 5 0.14) and the BAP group (NAP vs. BAP; p 5
0.40), this did not reach statistical significance.
On-treatment analysis. When the data were analyzed
using an on-treatment analysis, the results were similar to
those obtained by the intention-to-treat analysis. The inci-
dence of postoperative AF among patients who actually
received 72 h of pacing therapy was 13% (RAP, 11%; LAP,
15%; BAP, 24%) compared with 33% (p , 0.005) in those
in the NAP group.
Length of hospital stay. Overall, patients assigned to a
pacing strategy following surgery had a 22% reduction in
their length of hospital stay compared with patients who
were in the NAP group (6.1 6 2.3 days vs. 7.8 6 3.7 days;
p 5 0.003). Compared with a mean length of stay of 7.8 6
3.7 days for patients assigned to NAP, the mean length of
stay was 5.9 6 2.1 days for BAP, 6.8 6 2.9 days for LAP
and 5.6 6 1.4 days for RAP. When analyzed by individual
groups, the difference between NAP and RAP was signif-
icant (p 5 0.01); there was a trend toward a decrease in
hospital stay between NAP and BAP (p 5 0.08) and no
significant difference between NAP and LAP (Fig. 2).
DISCUSSION
The results of the present study have demonstrated that
postoperative atrial pacing in conjunction with beta-
blockers significantly reduced the incidence of AF following
Figure 1. Percentage of patients developing postoperative atrial fibrillation. The numbers above the bars indicate the percentage in each
group. There was a significant difference between NAP and RAP (p 5 0.002) while the difference between NAP and LAP as well as
between NAP and BAP did not reach statistical significance. Black bar 5 no pacing; hatched bars 5 pacing. BAP 5 biatrial pacing;
LAP 5 left atrial pacing; NAP 5 no atrial pacing; RAP 5 right atrial pacing.
Table 4. Postoperative Beta-Blocker Therapy
NAP RAP LAP BAP
p
Value
Initiation and maintenance of BB (%) 96 78 87 86 NS
Time until first dose of BB (h)* 19 6 9 22 6 24 13 6 7 22 6 20 NS
*Time from completion of surgery until first dose of beta-blocker.
BAP 5 biatrial pacing; BB 5 beta-blocker; LAP 5 left atrial pacing; NAP 5 no atrial pacing; RAP 5 right atrial pacing.
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cardiac surgery. This strategy also significantly shortened
the length of hospital stay.
Conventional treatment strategies. Atrial fibrillation is
the most common postoperative complication following
cardiac surgery (2). Although it usually does not result in
long-term sequelae, it does add significantly to morbidity,
utilization of hospital resources and the length of hospital-
ization (2,3). Treatment strategies have, until recently,
centered on the use of pharmacologic therapy. Beta-
blockers and more recently several of the class III antiar-
rhythmic agents have been shown to be effective in reducing
the incidence of postoperative AF (4–12). However, phar-
macotherapy has been limited by adverse effects and a
significant occurrence of AF even in patients receiving
optimal treatment.
Previous studies of atrial pacing for the prevention of
AF. The limited efficacy of conventional agents has led to
searches for nonpharmacologic modalities for the preven-
tion of postoperative AF. Coumel and colleagues (16,17)
were among the first to report the potential of pacing to
prevent AF almost a decade ago. They described the use of
single-site atrial overdrive pacing to prevent AF or flutter in
a select group of patients with vagally mediated AF or
flutter (16,17). Further studies by Murgatroyd et al. (18)
utilized a unique pacing algorithm for the suppression of
atrial premature depolarizations. This technique resulted in
a significant reduction in episodes of AF. The mechanism
by which atrial overdrive pacing reduces the occurrence of
AF is unclear, although suppression of atrial premature
depolarizations and a reduction in the dispersion of refrac-
toriness have all been proposed (19,20). The use of BAP
was shown by Daubert and associates (13) to be effective in
the prevention of atrial arrhythmias in patients with inter-
atrial conduction block. By simultaneous stimulation from
the right atrial appendage and the coronary sinus, the use of
BAP was believed to resynchronize the atrial electrical
activity and reduce intraatrial and interatrial asynchrony.
Subsequent work by Saksena and colleagues (14) demon-
strated the effectiveness of dual-site RAP in prolonging
arrhythmia-free intervals in a group of patients with drug-
refractory paroxysmal AF.
Despite the growing body of data demonstrating a role
for atrial pacing in the prevention of AF in the nonoperative
setting, its feasibility and efficacy following surgery remain
less clear. Recently, Gerstenfeld et al. (15) reported no
benefit with atrial pacing for the prevention of postoperative
AF. They did, however, note that for the subset of patients
who received both postoperative beta-blockers and atrial
pacing, there was a reduction in the incidence of AF,
suggesting that the combination of beta-blockade and atrial
pacing might be of particular benefit.
The present study. Our study was designed to determine
whether a treatment strategy of atrial-based pacing in
conjunction with beta-blockers would reduce the incidence
of AF following cardiac surgery. We demonstrated an
overall reduction in postoperative AF from 37.5% in pa-
tients receiving no pacing to 17% in patients assigned to one
of the postoperative pacing strategies. Of note, our 37.5%
incidence of postoperative AF in patients receiving only
beta-blockers, as well as the 8% incidence of AF in patients
assigned to RAP, is similar to that recently reported by
Gerstenfeld et al. (15). Although several investigators have
suggested that BAP may be more efficacious than single-site
pacing in reducing postoperative AF, in the present study,
the greatest reduction in postoperative AF was seen in
patients assigned to RAP. Although the present study
clearly demonstrates the ability of postoperative pacing to
reduce the occurrence of postoperative AF, inferences re-
garding a selective benefit of one form of pacing over
another must be tempered in view of the significant differ-
Figure 2. Effect of postoperative pacing on the length of postoperative hospitalization. The numbers above each bar indicate the number
of days spent in hospital following surgery. Black bar 5 no pacing; hatched bars 5 pacing. Abbreviations are listed in Figure 1.
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ences among the groups with respect to the ability to initiate
and maintain effective pacing. Because the ability to effec-
tively pace was significantly greater in patients assigned to
RAP, the lower incidence of AF in this group may be due
either to a selective advantage of RAP or to the fact that
RAP was more easily accomplished and maintained com-
pared with LAP or BAP.
Study limitation. Although we have used the term BAP to
imply simultaneous RAP and LAP, our actual technique
involved pacing the right and left atria by using the atrial
and ventricular ports of a temporary pacemaker with the
atrioventricular delay set to its lowest value (6 ms). There-
fore, there was actually a 6-ms delay between activation of
the right and left atria. Although independent right and left
atrial capture as well as changes in P-wave configuration
were documented at the initiation of pacing and every 8 h,
the possibility that biatrial capture was not maintained in all
cases cannot be completely excluded.
Since continuous Holter monitoring was not performed
on each patient, it is conceivable that some episodes of AF
were undetected. Several precautions were taken to mini-
mize this potential problem. Each patient underwent con-
tinuous electrocardiographic monitoring for at least 96 h
following surgery. In conjunction with continuous monitor-
ing, arrhythmia event–triggered alarms were prepro-
grammed for each patient. These sounded an audible alarm
as well as triggering an ECG recording anytime there was
an irregular heart rhythm or the heart rate exceeded a
prespecified upper rate limit (i.e., 110 to 120 beats/min). All
recorded events were retrieved for daily review. Routine
rhythm ECG strips were collected by nursing personal every
1 to 6 h for all patients. Finally, every medical chart was
reviewed separately by two physicians following patient
discharge from the hospital. All enclosed ECG strips,
nursing notes, vital signs and medication sheets were re-
viewed for any occurrences of AF.
While patients were randomized to the four different
treatment groups, there was a substantial difference in the
final number of patients in each group and while there were
no differences in the baseline characteristics among the
groups, the difference in group numbers must be viewed as
a potential limitation.
We chose as our primary end point the occurrence of
clinically significant AF. This was defined as either AF of
1 h duration or ,1 h but associated with hypotension, ECG
changes or the need for cardioversion. The possibility that
we did not detect short, self-limiting episodes of AF cannot
be dismissed, although to our knowledge, there are no data
to suggest that such episodes are clinically significant.
Finally, while pacing from the right atria was easily
initiated and maintained in the vast majority of patients, the
same was not true for both LAP and BAP. In a significant
proportion of cases, LAP and BAP could not be sustained
because of high pacing thresholds or diaphragmatic stimu-
lation. Unlike BAP in the nonoperative setting where LAP
is achieved via the coronary sinus, in our study, the position
of the left atrial epicardial electrodes probably resulted in
stimulation of the phrenic nerve. This resulted in a signif-
icant group of patients who could not have effective pacing
and hence the true clinical utility of this pacing strategy
must be interpreted in this light.
Clinical implications. Effective means for the prevention
of postoperative AF have so far been limited to the use of
beta-blockers and class III antiarrhythmic agents. The
present study describes a safe and effective nonpharmaco-
logic modality for the reduction of postoperative AF. The
procedure described is easily applied in the clinical setting.
The widespread utilization of postoperative atrial pacing
could have important implications with respect to utiliza-
tion of hospital resources, length of hospital stay and the
complications associated with postoperative AF. Further
studies are needed to better define the best anatomic site for
postoperative pacing.
Conclusions. Prophylactic atrial pacing in conjunction
with beta-blockers significantly reduced both the incidence
of postoperative AF and the length of hospital stay follow-
ing cardiac surgery.
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